Tag: Ocugen

Pennsylvania-based biotech firm Ocugen captured significant market attention on Friday as its stock reached a new 52-week peak. This substantial ...

Ocugen has captured market attention with a bold regulatory roadmap, announcing plans to submit three gene therapy applications to the ...

The biotech sector has a standout performer as Ocugen's stock demonstrates remarkable momentum, reaching fresh milestones while many peers struggle. ...

The biotechnology firm Ocugen has captured market attention with a remarkable performance surge, gaining more than 26% over a two-week ...

Ocugen is executing a strategic campaign to position itself at the forefront of gene therapy. The company has announced a ...

A surge in bullish options trading has drawn significant attention to biotech firm Ocugen, with market participants taking substantial positions ...

A single research report from Lucid Capital sent Ocugen shares skyrocketing on Tuesday, with the biopharmaceutical company experiencing a dramatic ...

Biotechnology firm Ocugen has announced a significant licensing agreement that marks its first regional partnership for experimental therapy OCU400. The ...

The biotech sector is witnessing a classic battle of opposing narratives play out in Ocugen shares. Conflicting developments from a ...

Biotechnology firm Ocugen confronts a significant strategic challenge following the abrupt termination of a major merger agreement. The collapse of ...